Siemens Healthineers AGLTS:0PMJ +0.50%79 Days Payable is 56.58 as of Mar. 2026, which is 1% above its 10-year median of 56.18. GuruFocus rates LTS:0PMJ with a GF Score™ of 79/100 and a GF Value™ of €52.27 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Siemens Healthineers AG ranks worse than 61.76% on this metric.
The historical rank and industry rank for Siemens Healthineers AG's Days Payable or its related term are showing as below:
LTS:0PMJ'
s Days Payable Range Over the Past 10 Years
Min: 43.86 Med: 56.18 Max: 59.02
Current: 56.16
During the past 11 years, Siemens Healthineers AG's highest Days Payable was 59.02. The lowest was 43.86. And the median was 56.18.
LTS:0PMJ's Days Payable is ranked worse than 61.76% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs LTS:0PMJ: 56.16
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0PMJ vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Siemens Healthineers AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Siemens Healthineers AG Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's Days Payable distribution charts can be found below:
* The bar in red indicates where Siemens Healthineers AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Siemens Healthineers AG's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Siemens Healthineers AG (LTS:0PMJ) has a Days Payable of 56.58 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Siemens Healthineers AG and its competitors. This is near median its historical median of 56.18. Over the past decade, Siemens Healthineers AG's Days Payable has ranged from 43.86 to 59.02. According to the industry distribution chart, Siemens Healthineers AG ranks #491 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 61.8%.
Is Siemens Healthineers AG's Days Payable too high?
Siemens Healthineers AG's current Days Payable of 56.58 is near median its 10-year median of 56.18. Over the past 10 years, this metric has ranged from a low of 43.86 to a high of 59.02. The Medical Devices & Instruments industry median Days Payable is 68.07. Siemens Healthineers AG's value of 56.58 is 16.9% below this industry median. Based on the distribution chart, Siemens Healthineers AG ranks #491 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Siemens Healthineers AG has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Siemens Healthineers AG ranks #491 out of 795 companies for Days Payable. This places Siemens Healthineers AG in the lower half of its industry. The industry median Days Payable is 68.07. Siemens Healthineers AG's value of 56.58 is 16.9% below this benchmark. Historically, Siemens Healthineers AG's own Days Payable has ranged from 43.86 to 59.02 over the past decade. While the company's 10-year median is 56.18 vs. the industry median of 68.07, Siemens Healthineers AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Siemens Healthineers AG's current Days Payable of 56.58 is 16.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Siemens Healthineers AG and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siemens Healthineers AG's current Days Payable is 56.58, which is near median its own 10-year median of 56.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Based on GuruFocus' analysis, Siemens Healthineers AG (LTS:0PMJ) is currently considered Possible Value Trap. The stock's GF Value™ is €52.27, compared to a current price of €34.85 — trading 33.3% below its estimated fair value. The current Days Payable is 56.58, which is near median its 10-year median of 56.18 and 16.9% below the Medical Devices & Instruments industry median of 68.07. Siemens Healthineers AG's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Siemens Healthineers AG (LTS:0PMJ), the current Days Payable is 56.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Siemens Healthineers AG (LTS:0PMJ) Overvalued in 2026?
Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued.
The current stock price of €34.85 is trading 33.3% below its estimated GF Value™ of €52.27.
GuruFocus considers Siemens Healthineers AG to be Possible Value Trap.
Key valuation signals for LTS:0PMJ:
Days Payable: 56.58 (near median its 10-year median of 56.18)
GF Value™: €52.27 vs. price of €34.85 (33.3% below fair value)
Industry Position: 16.9% below the Medical Devices & Instruments median (#491 of 795)
No single metric tells the full story. See the LTS:0PMJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
79GF Score
Get the complete analysis for LTS:0PMJ
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0PMJ has been successfully added to your 
